These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37898784)

  • 1. Immunized mice naturally process in silico-derived peptides from the nucleocapsid of SARS-CoV-2.
    Campos-Ruíz MA; Illades-Aguiar B; Del Moral-Hernández O; Romo-Castillo M; Salazar-García M; Espinoza-Rojo M; Vences-Velázquez A; Cortés-Sarabia K; Luna-Pineda VM
    BMC Microbiol; 2023 Oct; 23(1):319. PubMed ID: 37898784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine.
    Feng W; Xiang Y; Wu L; Chen Z; Li Q; Chen J; Guo Y; Xia D; Chen N; Zhang L; Zhu S; Zhao KN
    J Clin Lab Anal; 2022 Jun; 36(6):e24479. PubMed ID: 35527696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model.
    Rak A; Gorbunov N; Kostevich V; Sokolov A; Prokopenko P; Rudenko L; Isakova-Sivak I
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development and application of triple antibodies-based sandwich ELISA for detecting nucleocapsid protein of SARS-associated coronavirus].
    Qiu LW; Tang HW; Wang YD; Liao JE; Hao W; Wen K; He XM; Che XY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Apr; 26(4):277-81. PubMed ID: 15941537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of water-soluble nucleocapsid protein of SARS-CoV-2 and analysis of its immunogenicity.
    Wang YB; Wang SW; Jin QY; Chen LP; Zhang FQ; Shi JJ; Yin Y; Fan ZX; Liu XY; Wang LP; Li P
    Pol J Vet Sci; 2023 Dec; 26(4):571-579. PubMed ID: 38088301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.
    Yasui F; Kai C; Kitabatake M; Inoue S; Yoneda M; Yokochi S; Kase R; Sekiguchi S; Morita K; Hishima T; Suzuki H; Karamatsu K; Yasutomi Y; Shida H; Kidokoro M; Mizuno K; Matsushima K; Kohara M
    J Immunol; 2008 Nov; 181(9):6337-48. PubMed ID: 18941225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates.
    Liu SJ; Leng CH; Lien SP; Chi HY; Huang CY; Lin CL; Lian WC; Chen CJ; Hsieh SL; Chong P
    Vaccine; 2006 Apr; 24(16):3100-8. PubMed ID: 16494977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation and characterization of monoclonal antibodies against SARS-associated coronavirus nucleocapsid protein].
    Wang YB; Chang ZR; Wang JW; Ji R; Han CH; Zhao L; Ren LL; Chao YG; Qu JG; Qu CY; Hung T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):316-20. PubMed ID: 15650778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant highly antigenic truncated fusion-based protein as a diagnostic antigen for anti-SARS-CoV-2 nucleocapsid antibody ELISA.
    Salarifar A; Khalili S; Rasaee MJ
    Protein Expr Purif; 2023 Mar; 203():106200. PubMed ID: 36379348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients.
    Maghsood F; Shokri MR; Jeddi-Tehrani M; Torabi Rahvar M; Ghaderi A; Salimi V; Kardar GA; Zarnani AH; Amiri MM; Shokri F
    Pathog Dis; 2022 Feb; 80(1):. PubMed ID: 34994386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of ELISA Using Total Antibody against Plant-Expressed Recombinant Nucleocapsid Protein of SARS-CoV-2.
    Tariq M; Hur J; Seo JW; Kim DY; Yun NR; Lee YM; Bang MS; Hwang SY; Kim CM; Lee JH; Song KH; Lee H; Jung J; Park JY; Kim HB; Kim ES; Lee S; Kim DM
    Microbiol Spectr; 2021 Dec; 9(3):e0067221. PubMed ID: 34817278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
    Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
    J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
    Burbelo PD; Riedo FX; Morishima C; Rawlings S; Smith D; Das S; Strich JR; Chertow DS; Davey RT; Cohen JI
    J Infect Dis; 2020 Jun; 222(2):206-213. PubMed ID: 32427334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Biosensor of SARS-CoV-2 Using Specific Monoclonal Antibodies Recognizing Conserved Nucleocapsid Protein Epitopes.
    Lee JH; Jung Y; Lee SK; Kim J; Lee CS; Kim S; Lee JS; Kim NH; Kim HG
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
    Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Kao RY; Chan KH; Peiris JS; Yuen KY
    J Clin Microbiol; 2005 Jul; 43(7):3054-8. PubMed ID: 16000415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of in silico-identified-peptides in spike-S1 domain and nucleocapsid of SARS-CoV-2 for antibody detection in COVID-19 patients and antibody production.
    Cortés-Sarabia K; Luna-Pineda VM; Rodríguez-Ruiz HA; Leyva-Vázquez MA; Hernández-Sotelo D; Beltrán-Anaya FO; Vences-Velázquez A; Del Moral-Hernández O; Illades-Aguiar B
    Sci Rep; 2022 Sep; 12(1):15057. PubMed ID: 36064951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.
    Yue L; Cao H; Xie T; Long R; Li H; Yang T; Yan M; Xie Z
    J Med Virol; 2021 Mar; 93(3):1732-1738. PubMed ID: 32965677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
    Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
    J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies.
    Tian Y; Zhang G; Liu H; Ding P; Jia R; Zhou J; Chen Y; Qi Y; Du J; Liang C; Zhu X; Wang A
    Appl Microbiol Biotechnol; 2022 Feb; 106(3):1151-1164. PubMed ID: 35037999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and application of a series of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein.
    Zhou L; Mo C; Yang Y; Zhou Z; You A; Fan Y; Liu W; Li X; Zhou R; Tian X
    J Med Virol; 2023 Jan; 95(1):e28225. PubMed ID: 36238992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.